Drug Profile
Filibuvir
Alternative Names: PF-00868554; PF-868554Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Pfizer
- Class Antivirals; Pyrimidines; Small molecules
- Mechanism of Action DNA-directed RNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hepatitis C
Most Recent Events
- 28 Feb 2013 Discontinued - Phase-I for Hepatitis C in Japan (PO)
- 28 Feb 2013 Discontinued - Phase-II for Hepatitis C in Belgium (PO)
- 28 Feb 2013 Discontinued - Phase-II for Hepatitis C in Canada (PO)